Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
Go back to Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial| (NASDAQ: CMND) | Delayed: 0.80 -0.06 (6.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.86 | 52 Week High | $ | |||
| Open | $0.85 | 52 Week Low | $ | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.77 | EPS | $ | |||
| Volume | 194,696 | |||||
